Article info

PDF
Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial

Authors

  1. Correspondence toPascal Hendrik Pieter de Jong, Department of Rheumatology, University Medical Center, ErasmusMC, Room Ee963a, Postbus 2040, 3000CA Rotterdam, Netherlands; p.h.p.dejong{at}erasmusmc.nl
View Full Text

Citation

de Jong PH, Hazes JM, Barendregt PJ, et al
Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial

Publication history

  • Accepted March 25, 2012
  • First published June 7, 2012.
Online issue publication 
December 12, 2012

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.